Publication Archive - Epiconcept

Evaluating breast cancer screening performance without registries using medico-administrative data

Emilien Jemelen, Francisco Orchard, William Madie, Bernard Valentin, Josine Belin, Enora Laas, Guillaume Jeannerod, Pierre Mares, Sandrine Katsahian & Agathe Guilloux

Article number: 25096 (published 11 July 2025)

Available here

COVID-19 Vaccine effectiveness among Healthcare Workers during the Omicron Period in the country of Georgia, January – June 2022

Caleb L. Ward, Madelyn Yiseth Rojas Castro, Giorgi Chakhunashvili, Nazibrola Chitaze, Iris Finci, Richard Pebody, Esther Kissling, Mark A. Katz, Lia Sanodze.

May 21, 2025

Available here

Surveillance of severe acute respiratory infections associated with SARS-CoV-2, influenza virus and RSV using ICD-10 codes: a case definition accuracy study across five European countries, 2021-2023

Sanchez Ruiz Miguel Angel, Marques Diogo FP, Lomholt Frederikke Kristensen, Vestergaard Lasse Skafte, Monge Susana, Lozano Álvarez Marcos, Aspelund Gudrun, Thordardottir Marianna, Dziugyte Ausra, Cauchi John-Paul, Boere Tjarda M, Veldhuijzen Irene K, Seppälä Elina, Bøås Håkon, Paulsen Trine Hessevik, ESURE SARI group, Machado Ausenda, Rodrigues Ana Paula, Hooiveld Mariette, Alves de Sousa Luis, Torres Ana, Carvalho Carlos, Nunes Baltazar.

Euro Surveill. 2025;30(27):pii=2400748.

Available here

Evaluation of European severe acute respiratory infection (SARI) surveillance, 27 European countries, 2022/23

Marques Diogo FP, Kovacs Dory, Sanchez-Ruiz Miguel-Angel, Rodrigues Ana Paula, Machado Ausenda, Mazagatos Clara, Monge Susana, Domegan Lisa, O’Donnell Joan, Hooiveld Mariette, Emborg Hanne-Dorthe, Nunes Baltazar, Carvalho Carlos, Rose Angela MC

Euro Surveill. 2025;30(20):pii=2400655.

Available here

Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24

Kissling Esther, Maurel Marine, Pozo Francisco, Pérez-Gimeno Gloria, Buda Silke, Sève Noémie, Domegan Lisa, Hooiveld Mariëtte, Oroszi Beatrix, Martínez-Baz Iván, Guiomar Raquel, Latorre-Margalef Neus, Mlinarić Ivan, Lazar Mihaela, Giménez Duran Jaume, Dürrwald Ralf, Enouf Vincent, McKenna Adele, de Lange Marit, Túri Gergő, Trobajo-Sanmartín Camino, Gomez Verónica, Samuelsson Hagey Tove, Višekruna Vučina Vesna, Cherciu Maria Carmen, García Vazquez Miriam, Erdwiens Annika, Masse Shirley, Bennett Charlene, Meijer Adam, Kristóf Katalin, Castilla Jesús, Rodrigues Ana Paula, Kurečić Filipović Sanja, Ivanciuc Alina Elena, Bacci Sabrina, Kaczmarek Marlena, on behalf of the European primary care VE group

Euro Surveill. 2025;30(23):pii=2500011

Available here

COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network

Laniece Delaunay, C., Verdasca, N., Monge, S., Domegan, L., Sève, N., Buda, S., Meijer, A., Lucaccioni, H., López Torrijos, M., McKenna, A., Enouf, V., Dürrwald, R., In’t Velt, E., de Valcárcel Laiglesia, M., Bennett, C., Masse, S., Erdwiens, A., Hooiveld, M., Mlinarić, I., Túri, G., Rodrigues, A., Martínez-Baz, I., Lazar, M., Latorre-Margalef, N., Borges, V., Kaczmarek, M., Bacci, S., Kissling, E. and European primary care VE group

First published: 21 May 2025

Available here

Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024

Antunes L, Rojas-Castro M, Lozano M, Martínez-Baz I, Leroux-Roels I, Borg ML, Oroszi B, Fitzgerald M, Dürrwald R, Jancoriene L, Machado A, Petrović G, Lazar M, Součková L, Bacci S, Howard J, Verdasca N, Basile L, Castilla J, Ternest S, Džiugytė A, Túri G, Duffy R, Hackmann C, Kuliese M, Gomez V, Makarić ZL, Marin A, Husa P, Nicolay N, Rose AMC; VEBIS SARI VE network team.

2025 Mar;19(3):e70081. doi: 10.1111/irv.70081. PMID: 40059069; PMCID: PMC11890973.

Available here

Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023)

Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, Anneli Uusküla, Colm Bergin, Catherine Fleming, Viesturs Zvirbulis, Dace Zavadska, Konstanty Szułdrzyński, Vânia Gaio, Corneliu Petru Popescu, Mihai Craiu, Maria Cisneros, Miriam Latorre-Millán, Liis Lohur, Jonathan McGrath, Lauren Ferguson, Ilze Abolina, Dagne Gravele, Ausenda Machado, Simin Aysel Florescu, Mihaela Lazar, Pilar Subirats, Laura Clusa Cuesta, Jacklyn Sui, Claire Kenny, Dainis Krievins, Elza Anna Barzdina, Aryse Melo, Alma Gabriela Kosa, Victor Daniel Miron, Carmen Muñoz-Almagro, Ana María Milagro, Sabrina Bacci, Piotr Kramarz, Anthony Nardone.

Vaccine, Volume 45, 2025, 126615, ISSN 0264-410X

Available here

Building and Developing a Tool (PANDEM-2 Dashboard) to Strengthen Pandemic Management: Participatory Design Study

Tighe C, Ngongalah L, Sentís A, Orchard F, Pacurar GA, Hayes C, Hayes JS, Toader A, Connolly MA

JMIR Public Health Surveill 2025;11:e52119. doi: 10.2196/52119

Available here

COVID-19 vaccine effectiveness in the paediatric population aged 5–17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022

Soares Patrícia, Machado Ausenda, Nicolay Nathalie, Monge Susana, Sacco Chiara, Hansen Christian Holm, Meijerink Hinta, Martínez-Baz Iván, Schmitz Susanne, Humphreys James, Fabiani Massimo, Echeverria Aitziber, AlKerwi Ala’a, Nardone Anthony, Mateo-Urdiales Alberto, Castilla Jesús, Kissling Esther, Nunes Baltazar, VEBIS-Lot 4 working group.

Euro Surveill. 2025;30(8):pii=2400450.

Available here

Publication

Référencement Centrales d'achats

Hébergement de données de santé

Engagements et éthique

Satisfaction collaborateurs